Deal Closing?
|
|
Resverlogix Corp.
|
May 27, 2019 09:28PM
|
Dulaglutide
|
3
|
Resverlogix Corp.
|
Feb 25, 2020 12:43PM
|
Eli Lilly CFO Comment
|
7
|
Resverlogix Corp.
|
Jan 18, 2020 03:23PM
|
Financial Times article on UCSF Covid project about the 69 potential drugs
|
5
|
Resverlogix Corp.
|
May 01, 2020 12:40PM
|
Goldman Sachs
|
1
|
Resverlogix Corp.
|
Sep 19, 2019 01:38PM
|
Hedge Knight Capital Discussion
|
3
|
Resverlogix Corp.
|
May 25, 2019 08:22PM
|
Hepalink
|
6
|
Resverlogix Corp.
|
Feb 21, 2020 01:37AM
|
Hepalink IPO Document and what it says about RVX
|
8
|
Resverlogix Corp.
|
Jan 26, 2020 03:59PM
|
How the Synthorx (THOR) Story Evolved
|
4
|
Resverlogix Corp.
|
Dec 24, 2019 08:32AM
|
Last Few Days of the Trial
|
2
|
Resverlogix Corp.
|
Sep 16, 2019 10:23PM
|
MACE question
|
1
|
Resverlogix Corp.
|
Jun 20, 2019 09:05PM
|
Monday!
|
6
|
Resverlogix Corp.
|
Sep 26, 2019 07:06PM
|
My estimate for Top Line Data Announcement...is a shocker!
|
3
|
Resverlogix Corp.
|
Jun 05, 2019 07:45PM
|
My general impressions
|
7
|
Resverlogix Corp.
|
Nov 16, 2019 03:36PM
|
Patient Years & MACE rate Question
|
1
|
Resverlogix Corp.
|
Jul 10, 2019 06:24PM
|
Pfizer
|
4
|
Zenith Epigenetics
|
Jun 02, 2020 08:16PM
|
Pfizer's plans for research: sounds like RVX!
|
10
|
Resverlogix Corp.
|
Jan 29, 2020 11:45AM
|
Phase 3 Design
|
2
|
Resverlogix Corp.
|
Jun 23, 2019 10:23AM
|
Potential Buyers Have a Lot of Cash
|
3
|
Resverlogix Corp.
|
Dec 26, 2018 04:26PM
|
Question about Phase 2
|
3
|
Resverlogix Corp.
|
Mar 11, 2019 09:37PM
|